Mesentech - Company Profile - Tracxn

Oct 23, 2024 · Mesentech ranks 280th among 627 active competitors. 220 of its competitors are funded while 146 have exited. Overall, Mesentech and its competitors have raised over $20B …

CouponFollow Extension

$20
OFF

Mesentech - Company Profile - Tracxn

5 days from now

Oct 23, 2024 · Mesentech ranks 280th among 627 active competitors. 220 of its competitors are funded while 146 have exited. Overall, Mesentech and its competitors have raised over $20B …

tracxn.com

$3.89
OFF

Mesentech - Raised $3.89M Funding From 8 Investors - Tracxn

5 days from now

Nov 4, 2024 · Mesentech has raised a total funding of $3.89M over 2 rounds from 8 investors. Investors include WUTIF Capital, CureDuchenne and 6 others. Their latest funding round was …

tracxn.com

$15
OFF

Mesentech - Crunchbase Company Profile & Funding

5 days from now

Mesentech may be growing as it has recently raised $15 million for Phase 1 clinical trials, indicating an influx of capital to support its research and development efforts. Additionally, the …

crunchbase.com

$15
OFF

Mesentech - Products, Competitors, Financials, Employees, …

5 days from now

The company also announced it has raised a total of $15M in financing to date. About Mesentech Mesentech is a biotechnology company developing new therapies to treat diseases and …

cbinsights.com

$1.78
OFF

Mesenbio - Company Profile - Tracxn

5 days from now

Oct 25, 2024 · Mesenbio - Developer of of therapeutic solutions for arthritis treatment. Raised a total funding of $1.78M over 1 round from 2 investors. Founded by David Kuntin and Paul …

tracxn.com

$72
OFF

Genentech - Company Profile - Tracxn

5 days from now

Oct 6, 2024 · Genentech - R&D company focused on manufacturing drugs for multiple therapeutic areas. Acquired by Roche. Raised a total funding of $72.5M over 1 round from 5 investors. …

tracxn.com

FAQs about Mesentech - Company Profile - Tracxn Coupon?

What is mesentech?

Mesentech is a pre-clinical platform company developing drug-conjugates targeted to bone. Our first product is a regenerative medicine product that targets mesenchymal stem-cells with a potent (sub nano-molar) prostaglandin mimetic that is released selectively in bone resulting in bone-regeneration. ...

Who is Tracxn Technologies Limited?

Tracxn Technologies Limited is an India-based company, which offers a data intelligence platform. The Company operates a software-as-a-service (SaaS)-based platform, Tracxn, which scans the World Wide Web (Web) domain. The Company operates through the Platform Subscription segment. ...

Who invented mesentech?

Mesentech was founded by Dr. Robert Young, who led teams that discovered SingulAir, Vioxx, Arcoxia, ondanacatib, among others while leading medicinal chemistry at Merck. MES1022 is a clinical stage compound that regenerates muscle and bone with selective distribution to musculoskeletal compartments. ...

What is mesentech's lead program?

Mesentech’s lead program is a bone-targeted anabolic that stimulates bone regeneration. It is indicated for severe pediatric osteoporosis caused by brittle bone disease, Duchenne muscular dystrophy and as a consequence of steroid treatment. ...

What is mesentech's musculoskeletal drug?

Mesentech is developing innovative drugs that can selectively distribute to musculoskeletal tissue. These drugs carry payloads such as small-molecule hormones or anti-cancer agents. ...